Monitoring COPD Exacerbations Without Contact
Non-contact Proactive Remote Monitoring to Facilitate Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)
Life Detection Technologies · NCT05598983
This study tests if a special device can help people with COPD spot early signs of flare-ups while they sleep, so they can manage their condition better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Life Detection Technologies (industry) |
| Locations | 1 site (London) |
| Trial ID | NCT05598983 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify early signs of COPD exacerbations before patients recognize symptoms. Participants will use a device called DistaSense placed on their mattress to monitor biological signals during sleep, while also completing a daily COPD Assessment Test (CAT). The study seeks to determine which biological indicators are most effective in predicting exacerbations and how these compare to daily symptom assessments.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with a confirmed diagnosis of COPD who have experienced at least one exacerbation in the past year.
Not a fit: Patients who are pregnant or have a BMI greater than 45 kg/m2 may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enable earlier intervention for COPD exacerbations, potentially reducing hospitalizations and improving patient outcomes.
How similar studies have performed: While the approach of non-contact monitoring is innovative, similar studies have shown promise in early detection of exacerbations in other respiratory conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Confirmed diagnosis of COPD 2. 1 or more exacerbation in the last year 3. Aged over 18 years 4. Willing to use monitoring devices and complete study questionnaires 5. Adequate English 6. Signed consent form Exclusion Criteria: 1. Pregnancy 2. BMI greater than 45 kg/m2 3. Nil other, provided inclusion criteria are met.
Where this trial is running
London
- Royal Free Hospital — London, United Kingdom (RECRUITING)
Study contacts
- Principal investigator: John Hurst — University College, London
- Study coordinator: Eric Howie
- Email: ehowie@distasense.com
- Phone: 4084213151
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COPD Exacerbation